Default object view. Click to create a custom template, Node ID: 143100, Object ID: 84753

Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01)

Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01)

No relation

Yes

No relation

No

02/06/2016 7:00 pm

No